The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized ... analytics company GlobalData in an overview of ...
Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern University and Case Western Reserve University have developed the first ...